The Energy Code

Dr. Mike Belkowski
  • 3.8 (12)
  • ALTERNATIVE HEALTH
  • UPDATED WEEKLY

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

  1. 48 MINS AGO

    Shining Light on the Brain: Can Transcranial PBM Boost Athletic Performance — or Is It Mostly Hype?

    Transcranial photobiomodulation (tPBM) is blowing up in performance culture, but what does the evidence actually say? In this Deep Dive, Dr. Mike Belkowski breaks down a narrative review (7 studies total: 5 human, 2 animal) examining tPBM in sports medicine for performance enhancement and injury prevention. You’ll learn the proposed mechanisms (mitochondrial respiration via cytochrome c oxidase, nitric oxide dynamics, calcium signaling), what the studies report across motor output, cognition, reaction time, grip strength, balance, and TBI recovery, and why the biggest limiter right now is protocol inconsistency + weak controls. The concept is compelling, but the science isn’t ready for absolute claims — especially in TBI. (Educational content only, not medical advice.) - Article Discussed in Episode: Transcranial Photobiomodulation in Sports Medicine: Enhancing Athletic Performance and Injury Prevention - Key Quotes From Dr. Mike: “If the brain is a performance organ, and it is, then brain energy is a legitimate target.” “tPBM follows a biphasic response — more is not always better.” “Treat tPBM as a complement to the real levers: sleep, rhythm, training, nutrition.” “If the bottleneck is sleep debt and overtraining, no headset can outshine that.” “The most honest conclusion here is: promising signal, weak standardization, and a field that needs better trials before bold claims.” - Key points tPBM = red/NIR light delivered through the scalp to influence CNS function (PFC, motor cortex, network hubs). Evidence base is early + small: 7 studies; only 1 double-blind sham-controlled RCT in the set. Core proposed target: cytochrome c oxidase → ATP support; also NO displacement → better oxygen utilization/redox. Potential downstream effects: blood flow + signaling (calcium, cAMP/NF-κB) → plasticity/repair pathways. Some studies show signals in motor output (e.g., finger tapping), and reported changes in reaction time/balance/grip (often uncontrolled). Cognition/sleep/mood improvements are reported, but many findings are vulnerable to placebo and expectation effects. Animal TBI models show delayed benefits (days 5–28) and reduced neuroinflammation/synaptic loss. Best-controlled human trial in persistent post-TBI symptoms found no significant advantage vs placebo after adjustments. tPBM is biphasic: dose matters; “more” can blunt effects — parameters define outcomes. Bottom line: tPBM is a promising adjunct tool, not a proven performance or TBI therapy yet; athletes need better trials and standardized protocols. - Episode timeline 0:19–1:32 — What tPBM is + evidence reality check (7 studies; early/mixed) 1:32–4:34 — Mechanisms: CCO/ATP, nitric oxide, calcium signaling → plasticity/inflammation 4:34–6:57 — Why it matters for sports + review selection + bias caveats 7:08–9:19 — Motor output signals (finger tapping; grip/balance claims + control issues) 9:19–10:23 — Cognition/sleep/mood: plausible, but often placebo-sensitive 10:23–12:09 — Animal TBI: delayed recovery benefits + anti-inflammatory shifts 12:09–14:20 — Human TBI: impressive case reports vs the sham-controlled null result 14:20–17:14 — Protocol variability + why there’s no standardized “athlete TPBM dose” 17:14–18:35 — Translation challenges (skull thickness, hair, targeting) + safety notes 18:35–23:00 — Bottom line: promising adjunct; not proven; what athletes should do with this info - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    23 min

  2. 19 HRS AGO

    Taurine vs. Alzheimer’s: The Early-Phase Brain Shield Nobody’s Talking About

    Alzheimer’s isn’t a sudden event. Rather, it’s a slow cascade that begins years (often decades) before symptoms present themselves. This Deep Dive explores a review positioning taurine as an early-phase, disease-modifying candidate — not as a miracle cure, but as a multi-target stabilizer that may support brain resilience upstream of major circuit loss. We break down why “single-target, late-stage” strategies struggle, how taurine may influence amyloid oligomers, mitochondrial stability, oxidative stress, calcium regulation, proteostasis/ER stress, neuroinflammation, and synaptic function, and why the real question is timing: early window vs. late-stage collapse. Promising, not proven. (Educational content only, not medical advice.) - Article Discussed in Episode: Taurine as an Early-Phase Disease-Modifying Candidate for Alzheimer’s Disease - Key Quotes From Dr. Mike: “Alzheimer’s is not one pathway. It’s converging pathologies that amplify each other.” “A multi-target molecule (i.e., taurine) isn’t a magic cure; it’s a stabilizer, especially early.” “Energy failure isn’t a side issue. It’s part of the disease engine.” “Neuroinflammation isn’t just a response, it can become a driver.” “The real future is likely combination: early detection plus multi-layer neuroprotection.” - Key points Alzheimer’s begins long before diagnosis; early neuroprotection may be the highest-leverage window. Taurine is endogenous, brain-concentrated, BBB-transported, and generally well tolerated. Alzheimer’s is a network failure (energy + inflammation + proteostasis + calcium + synapses), not one pathway. Taurine may modulate amyloid oligomers (often more toxic than plaques) and aggregation kinetics. Taurine is framed as a mitochondrial stabilizer (membrane potential, ATP support, less ROS signaling). It may buffer calcium and reduce excitotoxic load while preserving physiological signaling. It may tune ER stress / UPR and proteostasis rather than blunt adaptive stress responses. Anti-inflammatory potential includes taurine chloramine (TauCl) as a resolution-type feedback signal. Synaptic preservation matters more than plaque count; taurine may support plasticity markers/BDNF–CREB in models. Clinical Alzheimer’s evidence is still limited → best framing: promising, stage-dependent, needs trials. - Episode timeline 0:19–1:06 — Why this approach is “opposite” of mainstream: early-phase neuroprotection 1:06–3:20 — What taurine is + why it’s translationally attractive (BBB transport, safety history) 3:20–5:30 — Alzheimer’s as network collapse; limits of late single-target strategies 5:30–8:49 — Amyloid domain: oligomers vs plaques; taurine’s aggregation/oligomer modulation 8:49–12:59 — Mitochondria/ROS domain: stability, ATP support, less redox overload 12:59–15:28 — Proteostasis/ER stress domain + MAM/cross-talk framing 15:28–17:18 — Calcium/excitotoxicity + excitation/inhibition balance 17:18–19:06 — Neuroinflammation + TauCl as resolution-style mechanism 19:06–21:23 — Synaptic preservation + plasticity signaling (BDNF/CREB) 21:23–23:56 — Evidence breadth (models/organoids) + gaps and clinical limitations 23:56–27:25 — Take-home: stage-dependent strategy, resilience framework, “promising not proven” - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    28 min

  3. 1D AGO

    Microplastics in the Brain? The Non-Hysterical Science of Neurodegeneration Risk

    Microplastics and nanoplastics are now a near-constant modern exposure. This Deep Dive stays calm and scientific: detection is not causation, but detection across human tissues changes what’s plausible — and the paper builds a mechanistic map linking plastic particles to neurodegeneration-relevant biology through (1) gut barrier integrity, (2) microbiome + metabolites, (3) systemic immune activation and blood–brain barrier vulnerability, and (4) oxidative stress with nuclear + mitochondrial epigenetic reprogramming. The key theme isn’t panic, it’s resilience: reduce easy exposures without fear spirals, while building the biology that buffers stressors (sleep, circadian alignment, movement, metabolic stability, micronutrients, and gut health). (Educational content only, not medical advice.) - Article Discussed in Episode: Nuclear and Mitochondrial Epigenetic Mechanisms Underlying Neurodegeneration and Gut–Brain Axis Dysregulation Induced by Micro- and Nanoplastics - Key Quotes From Dr. Mike: “The question isn’t ‘should we panic?’ It’s ‘what does the science suggest, and how do we build resilience without hysteria?’” “Neuroinflammation doesn’t automatically mean neurodegeneration, but it lowers resilience.” “Epigenetic changes can persist after an exposure ends — they change the threshold for dysfunction.” “The biggest risk isn’t one exposure flipping a switch overnight; it’s chronic stressors lowering resilience over time.” “If the blood–brain barrier gets more permeable, the brain doesn’t just ‘feel’ inflammation — it inherits it.” - Key points Size is the story: microplastics (~1 µm–5 mm) vs nanoplastics (1 µm) behave differently systemically. Main exposure routes: ingestion (food/water) + inhalation; skin contact may matter in some settings. Exposure science is messy: studies report particle count/size/shape vs mass, making real-world dosing hard. Detection ≠ causation, but detection in tissues/fluids changes plausibility of systemic distribution. Proposed 4-domain model: gut barrier → microbiome/metabolites → immune tone/BBB → oxidative + epigenetic remodeling. Barrier crossing is context-dependent: inflammation, dysbiosis, alcohol, sleep disruption, stress may increase permeability. Immune signaling shifts can activate NF-κB-type inflammatory programs and strain NRF2-type antioxidant defenses. Dysbiosis matters because metabolites are signals (SCFAs like butyrate; tryptophan/indole metabolites; bile acids). Epigenetics is the “memory layer”: changes in methylation/histones/microRNAs can persist after exposure. Mitochondria are a key convergence point: oxidative stress can disrupt membrane potential, cristae, OxPhos, and stress responses like mitophagy. Practical frame: don’t obsess over one exposure — raise baseline resilience and reduce easy exposure sources. - Episode timeline 0:19–1:20 — Frame: non-hysterical resilience + core mechanistic map 1:17–2:33 — Definitions + exposure routes + why dose comparisons are hard 2:37–3:55 — Tissue detection: why it matters (without claiming causation) 4:04–6:23 — Domain 1: gut barrier integrity + size/context-dependent uptake 6:23–7:24 — Domain 2: immune activation (NF-κB / NRF2 framing) 7:24–10:27 — Domain 3: microbiome shifts → metabolite signaling → resilience 10:27–13:50 — Domain 4: nuclear + mitochondrial epigenetic remodeling + oxidative stress convergence 13:50–15:10 — What the paper doesn’t claim + why properties/co-exposures matter 15:14–18:43 — Practical “Energy Code” takeaways: reduce easy exposures + build baseline resilience - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    19 min

  4. 2D AGO

    Your Liver Clock Controls Your Muscle Energy (Even If You Sleep “Fine”)

    Most people think circadian rhythm is just sleep hygiene. This deep dive shows it’s metabolic infrastructure. In a hepatocyte-specific BMAL1 knockout mouse model, skeletal muscle clock genes kept oscillating — but a huge slice of muscle metabolic rhythms didn’t. Roughly 1/3 of rhythmic muscle genes were re-tuned when the liver clock was disrupted, and the biggest hit landed on mitochondrial respiration: over half of oscillatory oxidative phosphorylation genes changed. Even more compelling, serum transfer experiments showed the liver clock helps deliver a nighttime endocrine “upshift” signal that primes muscle cells for oxidative phosphorylation and ATP output. Translation: when circadian timing breaks, your organs stop cooperating and that “random fatigue” can be a timing problem, not a motivation problem. (Educational content only, not medical advice.) - Article Discussed in Episode: The liver clock tunes transcriptional rhythms in skeletal muscle to regulate mitochondrial function - Key Quotes From Dr. Mike: “The liver is not just a metabolic organ, it’s a timing organ.” “Your liver’s internal clock isn’t just running liver chemistry, it’s tuning mitochondrial function in skeletal muscle.” “About one third of rhythmic muscle genes are influenced by the liver clock.” “If your clocks are misaligned, your organs stop cooperating and the symptoms look like fatigue, cravings, and poor recovery.” “Longevity and performance aren’t only about what you do — they’re about when you do it.” - Key points Liver clock ≠ muscle clock control: muscle core clock rhythms stayed largely intact even when hepatocyte BMAL1 was deleted. But the liver clock tunes muscle metabolism: ~30.5% of rhythmic muscle genes shifted with liver clock disruption. Rhythmic gene changes split into: ~14.7% lost oscillation, ~14.1% gained oscillation, ~1.7% changed phase/amplitude. Carb metabolism rhythms were most resilient (~85.2% unaffected). Lipid metabolism rhythms were more sensitive (~26.9% affected). Mitochondrial programs were hit hardest: ~35.8% of mitochondrial envelope rhythmic genes affected. OxPhos was the headline: ~58.3% of oscillatory oxidative phosphorylation genes were affected. Active-phase serum is the signal carrier: WT night serum upregulated ribosomal + OxPhos genes in myotubes. Liver clock disruption breaks the night signal: ZT16 serum from knockout mice altered 136/210 serum-responsive genes vs WT. Functional readout matched: myotubes treated with knockout dark-phase serum showed lower ATP production(Seahorse). Practical translation: circadian alignment = organ cooperation, and “energy dips” may reflect mistimed endocrine signaling. - Episode timeline 0:19–1:40 — The thesis: circadian rhythm + liver + muscle mitochondria are one network 1:42–3:12 — Circadian basics + BMAL1 as the non-redundant clock driver 3:15–4:55 — Model: hepatocyte-specific BMAL1 knockout; muscle clock genes largely intact 5:00–6:20 — The headline: ~30.5% of rhythmic muscle genes shift with liver clock disruption 6:20–9:30 — Pathway impacts: carbs resilient; lipids sensitive; OxPhos heavily affected (~58.3%) 9:41–12:45 — Serum transfer experiments: WT night serum induces OxPhos/ribosome genes; knockout night serum breaks it 13:33–14:30 — Function test: Seahorse shows lower ATP production with knockout dark-phase serum 16:00–18:45 — What might the signal be? hepatokines, metabolites, EVs; secretion machinery may be altered 19:35–22:53 — Practical takeaways: timing as infrastructure; meal timing + morning light; energy dips as timing problem 22:53–23:15 — Close: “not just what you do — when you do it” - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    24 min

  5. 4D AGO

    Does Red Light Therapy Actually Work? 3 Studies, 3 Very Different Answers

    Photobiomodulation (PBM) and low-level light therapy (LLLT) are everywhere, and so are the claims: more ATP, better recovery, fat loss, nervous system balance, strength gains… all from the same “red light” buzzword. In this 3-paper masterclass, Dr. Mike Belkowski breaks the hype down into evidence, endpoints, and bottlenecks. You’ll get a clean, practical analysis of three very different PBM applications: Body circumference reduction (systematic review of sham-controlled RCTs) Autonomic nervous system regulation using HRV after infra-auricular/vagus-region PBM (randomized controlled trial) Upper-body performance on a real-world compound lift (bench press) in collegiate athletes (double-blind repeated-measures) Then we connect the dots: why PBM can show a strong signal in one domain, a weak signal in another, and no signal at all when the limiting factor isn’t mitochondrial energy; but coordination, sleep, stress, or recovery terrain. Bottom line: light is real, but its application is not universal — it works when the tool matches the job. (Educational content only, not medical advice.) - Articles Discussed in Episode: The influence of photobiomodulation on upper body muscular performance in collegiate athletes Effects of Acute Photobiomodulation on Heart Rate Variability in Physically Active Individuals: A Randomized and Controlled Clinical Trial Low-level laser therapy for reducing body circumferences: a systematic review - Key Quotes From Dr. Mike: “The PBM trap is thinking ‘more ATP’ automatically means better everything.” “Light therapy is real, but real does not mean universal. It means context-dependent.” “HRV is a moving target — sleep, caffeine, hydration, stress can drown out small effects.” “If you want nervous system balance, the big levers are still sleep, rhythm, breath, and training load.” “Ask better questions: what tissue, what depth, what dose, what endpoint?” - Key points PBM is a signal, not a guarantee → Match the tool to the job. Paper 1 (LLLT body contouring): short-term circumference reductions beat sham; high satisfaction; good tolerability; only 3 RCTs → promising but early. Devices/wavelengths varied (e.g., 532 nm, 635 nm, 635–680 nm) → can’t yet define “best protocol.” Follow-up windows were short (weeks) → durability still unknown long-term. Mechanism proposed: adipocyte emptying/pores (adipocytolysis / lipid peroxidation) more than guaranteed fat-cell death → lifestyle may determine persistence. Paper 2 (HRV/vagus-region PBM): acute 660 nm infraauricular PBM showed minimal HRV changes in healthy active adults; one entropy metric differed. HRV is a noisy systems output influenced by many variables; acute PBM may be underdosed or target too indirect. Paper 3 (bench press): PBM did not beat sham for 1RM, volume load, or soreness; baseline-to-week improvement likely learning/familiarization, not light. As movement complexity increases, PBM’s effect may drop if the limiter is coordination/neural drive, not local muscle energetics. Core takeaway: PBM efficacy is bottleneck-dependent—hit the bottleneck, see signal; miss it, see nothing. - Episode timeline 0:02–1:58 Setup: PBM isn’t magic—3 papers, 3 targets, 3 outcomes 1:59–14:48 Paper 1: LLLT body circumference systematic review (signal + limits) 15:19–21:47 Paper 2: Vagus-region PBM + HRV trial (mostly null; why that matters) 22:15–28:57 Paper 3: Bench press performance trial (PBM vs sham; no advantage) 29:01–35:19 Compare/contrast: endpoints, bottlenecks, evidence strength, mechanism chain length 35:38–37:23 Practical decision framework by goal (contouring vs HRV vs compound strength) 37:31–39:55 Final thesis: PBM works sometimes — context, dose, and bottleneck decide - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    41 min

  6. 4D AGO

    AI vs The Biological Clock: Mitochondria, Oxidative Stress & Telomeres

    Reproductive aging isn’t just your birthday — it’s biology. In this Deep Dive, Dr. Mike Belkowski breaks down the emerging science of AI in fertility assessment and why the next wave of reproductive medicine will move beyond single-marker thinking (AMH, FSH, AFC, semen analysis) into a multi-dimensional model built on three interconnected pillars: mitochondrial function, oxidative stress, and telomere biology. You’ll learn why egg and sperm quality decline is fundamentally an energy and redox story, why the most meaningful biomarkers are often hard to use clinically (invasive, destructive, non-standardized), and how AI can realistically change the game through imaging, pattern recognition, and multi-omics integration — without replacing clinicians. We also cover the real-world constraints: data quality, bias, explainability, validation, regulation, and privacy; because the future isn’t hype, it’s precision. (Educational content only, not medical advice.) - Article Discussed in Episode: Artificial Intelligence in Assessing Reproductive Aging: Role of Mitochondria, Oxidative Stress, and Telomere Biology - Key Quotes From Dr. Mike: “Fertility decline happens at the level of energy, oxidative stress, and cellular timekeeping.” “Oocytes are an ATP-intensive cell type; energy is the limiting factor.” “ROS isn’t the villain—uncontrolled ROS is the villain.” “Mitochondria, oxidative stress, and telomeres aren’t separate — they amplify each other.” “AI won’t replace clinicians—it can integrate complexity humans can’t.” “The next frontier is multi-layer prediction: hormones + imaging + mitochondrial competence.” - Key points Reproductive aging is biological, not just chronological. The “big 3” drivers: mitochondrial dysfunction + oxidative stress + telomere dynamics. Standard markers (AMH/FSH/AFC; semen analysis) don’t fully predict gamete quality/outcomes. Oocytes are mitochondria-dense; ATP is required for spindle formation, segregation, fertilization, early development. Sperm rely on mitochondria for motility, capacitation, DNA integrity. Mitochondrial biomarkers: mtDNA copy number, membrane potential, ATP, ROS—but many tests are invasive/destructive. ROS is necessary at physiologic levels; excess ROS drives DNA/lipid/protein damage and reproductive decline. Telomeres: shorter telomeres correlate with worse female outcomes; male telomere dynamics differ, but oxidative stress still harms telomeres/DNA. These pillars amplify each other: mito dysfunction → ROS ↑ → telomere damage ↑ → cellular aging ↑. AI’s current traction: embryo grading, IVF outcome prediction, computer-vision sperm analysis. Next frontier: AI integrating hormones + imaging + mitochondrial/oxidative/telomere biomarkers + lifestyle/exposures. Adoption requires explainability, multi-center validation, bias control, privacy, and clear accountability. - Episode timeline 0:19–2:29 Why AI is about to reshape fertility assessment + the 3 pillars framework 2:46–5:32 Mitochondria in eggs/sperm + key mito biomarkers + why testing is hard clinically 5:37–7:42 Oxidative stress: why ROS is both necessary and dangerous + biomarkers + standardization issues 7:42–9:33 Telomeres: female vs male dynamics + the amplification loop (mito ↔ ROS ↔ telomeres) 9:43–11:23 Where AI already works: embryo grading, IVF prediction, sperm analysis + what’s next 11:23–12:34 Real-world constraints: explainability, bias, heterogeneity, validation, regulation, privacy 12:37–15:28 The Energy Code takeaway: fertility as “energy age” + personalized levers + responsible precision 15:35–16:15 Tease: what a next-gen AI fertility clinic could look like - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    17 min

  7. 5D AGO

    Scar Reset: Microneedling + Light + Methylene Blue (The Keloid Breakthrough)

    Most people treat scars like an aesthetic afterthought, but hypertrophic scars and keloids are biologically active tissue: itchy, painful, stiff, inflamed, and often stubbornly persistent. In this Energy Code Deep Dive, Dr. Mike Belkowski breaks down a randomized double-blind clinical trial using a synergistic 3-part approach: microneedling + photodynamic therapy + methylene blue as the photosensitizer. We walk through the exact protocol (5 weekly sessions), how results were measured (JSS + POSAS), and what actually improved — thickness, stiffness, pain, itching, flexibility, pigmentation, vascularity, and patient satisfaction. We also discuss why controlled ROS under photodynamic therapy is different from chronic oxidative stress, why keloids may respond better to 1% methylene blue, and what “resetting the remodeling environment” really means. (Educational content only, not medical advice.) - Article Discussed in Episode: Redefining scar quality: A synergistic approach with micro-needling and photodynamic therapy using methylene blue as a photosensitizer: a randomized clinical trial - Key Quotes From Dr. Mike: “Scars aren’t just leftover tissue... they’re often biologically active.” “Microneedling opens the pathway. Light delivers the signal. Methylene blue is the photochemical tool.” “ROS (reactive oxygen species) isn’t ‘bad’— chronic ROS is bad. Controlled ROS can be therapeutic.” “If you want to change tissue outcomes, you often have to change the tissue environment.” “Methylene blue isn’t just a ‘mitochondria molecule'. In the right context, it’s a precision photochemical lever.” - Key points   Scars are biology, not just cosmetics; keloids/hypertrophic scars can stay inflamed and symptomatic. Trial design: randomized double-blind; 37 patients / 94 scars; 5 sessions, weekly. 4 groups: keloid vs hypertrophic × 0.1% vs 1% methylene blue. Protocol: microneedling (≈1–3 mm) → apply MB → occlude 30 min → light 15 min. Measured with JSS + POSAS (clinician + patient symptoms). Severity drop: JSS score fell roughly 14.69 → 4.69 by 6 months. POSAS: ~50% improvement after treatment; stable through 6 months. Biggest symptom wins: stiffness ↓ ~71%, itching ↓ ~70%, pain ↓ ~69%. 1% MB tended to outperform 0.1% for keloids (stronger photosensitizing effect/penetration). Low adverse events; keloid recurrence ~2% at 6 months; none reported for hypertrophic scars in that window. Mechanism logic: microneedling “restarts remodeling” + MB-PDT generates targeted ROS to modulate fibroblasts/collagen/inflammation. Limitations: small sample, no untreated control, subjective scales, limited objective imaging, follow-up only 6 months. - Episode timeline 0:19–1:31 Why scars are biology + the 3-part stack (microneedling + PDT + methylene blue) 1:36–2:17 Hypertrophic vs keloid + why standard care struggles (recurrence/side effects) 2:20–4:25 Trial setup: 37 patients / 94 scars, 4 groups, 5 weekly sessions + parameters 4:25–5:03 Outcomes measured: JSS + POSAS (clinician + patient symptoms) 5:05–6:13 Results: big drops in severity + symptom relief (stiffness/itching/pain) 6:13–7:37 Dose logic: 1% vs 0.1% MB + “controlled ROS” explanation 7:44–9:48 Mechanism: fibroblasts/collagen remodeling + why the combo is synergistic 9:51–10:48 Safety + recurrence + limitations (and what future trials need) 11:00–14:18 BioLight philosophy: stacking inputs, changing the environment, next steps - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    15 min

  8. MAR 5

    Biohacking Isn’t a Stack — It’s a Science: The Mitochondria-First Framework That Cuts Through the Noise

    This episode is a graduate-seminar style scholarly review of biohacking; not as a vibe or a shopping list, but as an ecosystem of claims, evidence types, incentives, and failure modes. Dr. Mike Belkowski walks through peer-reviewed biochemical arguments, academic frameworks, consumer books, surveys, mainstream media translation, and manifesto-style writing — then filters it all through one lens: mitochondria, redox balance, inflammation control, cellular cleanup, and the upstream metabolic terrain that determines whether “hacks” create resilience or just add noise. You’ll learn why changing 12 variables at once isn’t a protocol (it’s a story), why wearables are dashboards (not engines), how constraints like sleep and circadian rhythm govern everything downstream, and how to use evidence-tiering to separate real effects from compelling narratives. The end result is a practical, mitochondria-first framework: define outcomes, stabilize the baseline, add one lever at a time, and let measurement be the referee... not your identity. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: ​“Biohacking is not one discipline, it’s an ecosystem.” “You can feel like you’re doing a lot while actually destabilizing your physiology.” “People change too many variables too quickly — they never stabilize long enough to see what’s helping.” “The stress of tracking becomes a biological stressor.” “A real biohack improves the slope of recovery and the durability of function.” - Key points Biohacking is an ecosystem, not a single discipline; it contains truth, hype, and ideology. The scholarly move: classify claims by mechanism, evidence type, and limits. Real “biohacking” = shifting upstream terrain (metabolic state), not adding tricks. City analogy: fix the power grid (mitochondria/redox/inflammation) before buying “better cars” (more tools). Maximalist stacks (12 changes at once) create stories, not causal protocols. Health is constrained by fundamentals: sleep, circadian rhythm, movement, nutrients, stress load. Wearables are dashboards: they inform iteration, but don’t change the engine by themselves. Surveys show adoption truth: protocols must be sustainable (time/cost barriers matter). Media rewards novelty → often overemphasizes shortcuts and underemphasizes constraints. Manifesto writing can weaponize mitochondrial language into overconfident worldviews. Common failure modes: novelty addiction, metric worship, evidence flattening, baseline neglect, context blindness. Use evidence tiers to guide safety and precision (don’t treat anecdotes like RCTs). Build a stack like a scientist: one goal, few metrics, one variable at a time. A “real stack” is earned through validated iteration, not purchased. - Episode timeline 0:02–1:31 — Setup: “scholarly review” of biohacking through a mitochondria-first lens; sources overview 1:31–4:57 — Biohacking = ecosystem; classification; metabolic terrain + “city/grid” analogy 4:57–8:15 — Maximalist stack critique; constraints; dashboards vs engines; measurement vs entertainment 8:15–10:52 — Consumer books + surveys + media framing: adoption, hype incentives, sustainability 10:52–12:57 — Manifesto layer: how mitochondria language can out-run evidence 12:57–14:49 — Failure modes (novelty addiction, metric worship, evidence flattening, baseline neglect, context blindness) 14:49–19:47 — Evidence-tiering + what “effectiveness” really means (subjective → functional → biomarkers → long-term) 19:47–23:04 — Practical method: define outcome, simplify metrics, fix terrain, add one lever, evaluate humbly, build stack 23:04–26:59 — Personas + closing thesis: biohacking works when it respects biology, evidence, dose, context, and constraints - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    28 min
See All (288)

3.8
out of 5
12 Ratings

About

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

Information

  • Creator
    Dr. Mike Belkowski
  • Years Active
    2021 - 2026
  • Episodes
    288
  • Rating
    Clean
  • Copyright
    © Copyright 2021 All rights reserved.
  • Show Website
    The Energy Code

You Might Also Like